Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson’s disease
Frontiers in Pharmacology · 24.08.2026 · 17
DOI: 10.3389/fphar.2026.1886917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.08.2026. Verfasst von Oscar Arias-Carrión und 5 weiteren Autor:innen. Beteiligte Einrichtung: División de Neurociencias Clínica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico. Die Arbeit nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Parkinson’s disease (PD) is traditionally described as a dopaminergic neurodegenerative disorder driven by α-synuclein aggregation and selective neuronal loss in the substantia nigra pars compacta. While this characterization captures the core clinical and pathological features, it does not fully explain disease initiation and progression. Converging evidence from human genetics, cellular and structural biology, and systems neuroscience now supports a unified framework in which PD results from the progressive erosion of mitochondrial resilience. Here, mitochondrial resilience denotes the capacity of neuronal mitochondrial networks to withstand stress and recover bioenergetic and cellular homeostasis through coordinated quality control, metabolic adaptation, and organelle communication. Rare, high-impact monogenic mutations in PINK1 , PRKN (encoding Parkin), PARK7 ( DJ-1) , LRRK2 , and SNCA , along with common risk variants identified in genome-wide association studies, converge on interconnected pathways that govern mitochondrial quality control, bioenergetics, organelle dynamics, and cellular stress responses. These vulnerabilities are most pronounced in the highly energetic dopaminergic neurons of the substantia nigra, where sustained calcium cycling, high bioenergetic demand, and environmental stressors increase cellular susceptibility. Research has moved beyond early observations of respiratory chain impairment and oxidative stress to reveal context-specific disruptions in PINK1/Parkin-mediated mitophagy, lysosomal trafficking, mitochondrial-derived vesicle dynamics, and neuroimmune signaling. This integrated framework reframes PD as a disorder of impaired cellular maintenance rather than solely a consequence of late-stage degenerative processes. It provides a translational shift from mechanism-based biomarkers to early detection of mitochondrial failure and supports therapeutic strategies aimed at restoring mitochondrial function and resilience, offering a direct route to disease-modifying neuroprotection in PD and potentially other neurodegenerative disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- División de Neurociencias Clínica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
- Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
- Laboratory of Regenerative Medicine, Department of Physiology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
- Laboratorio de Investigación en Neurociencias y Enfermedades Neurodegenerativas (LINEN), Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, Mexic…
- Laboratorio de Neuroinmunobiología Molecular, Instituto de Neurociencias Traslacionales, CUCS, Universidad de Guadalajara, Guadalajara, Mexico.
Zitieren
APA
Arias-Carrión, O., Guerra-Crespo, M., Soto-Rojas, L. O., Valle, Y., Ortega-Robles, E., & Ortuño-Sahagún, D. (2026). Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson’s disease. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1886917
Vancouver
Arias-Carrión O, Guerra-Crespo M, Soto-Rojas LO, Valle Y, Ortega-Robles E, Ortuño-Sahagún D. Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson’s disease. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1886917
BibTeX
@article{AriasCarrin2026,
author = {Arias-Carrión, Oscar and Guerra-Crespo, Magdalena and Soto-Rojas, Luis O and Valle, Yeminia and Ortega-Robles, Emmanuel and Ortuño-Sahagún, Daniel},
title = {Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson’s disease},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1886917}
}
EUVIMED